Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chan

Showing results (1331-1340 of 1,535) with videos related to

Pageof 154
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2012
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapyA Harrer, H Tumani, S Niendorf, et al.
The Journal of Clinical Investigation|March 16, 2026
T cell-intrinsic VISTA expression promotes resistance to CTLA-4 blockade by restricting CD8+ T cell responsesCassandra Gilmour, Elizabeth DeLaney, Prerana B Parthasarathy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trialY Guo, M-J Ahn, A Chan, et al.
Science (New York, N.Y.)|December 9, 2017
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapyDiego Chowell, Luc G T Morris, Claud M Grigg, et al.
Plos Biology|July 19, 2023
Targeting AAV vectors to the central nervous system by engineering capsid-receptor interactions that enable crossing of the blood-brain barrierQin Huang, Albert T Chen, Ken Y Chan, et al.
Cancer Research|September 28, 2016
Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical OutcomesAndriy Marusyk, Doris P Tabassum, Michalina Janiszewska, et al.
Science (New York, N.Y.)|August 28, 2012
Genome sequencing identifies a basis for everolimus sensitivityGopa Iyer, Aphrothiti J Hanrahan, Matthew I Milowsky, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Spatial epigenomic niches underlie glioblastoma cell state plasticitySam Kint, Subhi Talal Younes, Shuozhen Bao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2025
Phase II trial of cabozantinib in combination with nivolumab for advanced extrapancreatic neuroendocrine tumors (epNET)Kimberly J Perez, Nora Horick, Joanna Baginska, et al.
Practical Radiation Oncology|June 4, 2014
Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local controlJennifer Y Wo, Stephanie K Childs, Jackie Szymonifka, et al.
Pageof 154

Showing results (1331-1340 of 1,535) with videos related to

Sort By:
Pageof 154
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2012
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapyA Harrer, H Tumani, S Niendorf, et al.
The Journal of Clinical Investigation|March 16, 2026
T cell-intrinsic VISTA expression promotes resistance to CTLA-4 blockade by restricting CD8+ T cell responsesCassandra Gilmour, Elizabeth DeLaney, Prerana B Parthasarathy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trialY Guo, M-J Ahn, A Chan, et al.
Science (New York, N.Y.)|December 9, 2017
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapyDiego Chowell, Luc G T Morris, Claud M Grigg, et al.
Plos Biology|July 19, 2023
Targeting AAV vectors to the central nervous system by engineering capsid-receptor interactions that enable crossing of the blood-brain barrierQin Huang, Albert T Chen, Ken Y Chan, et al.
Cancer Research|September 28, 2016
Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical OutcomesAndriy Marusyk, Doris P Tabassum, Michalina Janiszewska, et al.
Science (New York, N.Y.)|August 28, 2012
Genome sequencing identifies a basis for everolimus sensitivityGopa Iyer, Aphrothiti J Hanrahan, Matthew I Milowsky, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Spatial epigenomic niches underlie glioblastoma cell state plasticitySam Kint, Subhi Talal Younes, Shuozhen Bao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2025
Phase II trial of cabozantinib in combination with nivolumab for advanced extrapancreatic neuroendocrine tumors (epNET)Kimberly J Perez, Nora Horick, Joanna Baginska, et al.
Practical Radiation Oncology|June 4, 2014
Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local controlJennifer Y Wo, Stephanie K Childs, Jackie Szymonifka, et al.
Pageof 154